Risk Factors for Graft Failure with Busulfan/Fludarabine-Based Conditioning in Children Undergoing Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders

被引：0
|
作者：
Huang, Benjamin [1 ]
Dvorak, Christopher C. [2 ]
Wahlstrom, Justin [3 ]
Hwang, Jimmy [4 ]
Long-Boyle, Janel R. [3 ]
Cowan, Morton Jerome [2 ]
Horn, Biljana N. [1 ]
机构：
[1] UCSF Benioff Childrens Hosp, San Francisco, CA USA
[2] Blood & Marrow Transplant Program, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] High-Exposure, Targeted Daily Busulfan and Fludarabine-Based Conditioning for Children Undergoing Hematopoietic Stem Cell Transplantation for Inherited Metabolic Disorders: Outcomes at a Single Center
    Miller, Weston P.
    Stricherz, Melisa Kay
    Jennissen, Cathryn
    Sando, Nicole
    Danielson, Jennifer
    Lund, Troy
    Orchard, Paul J.
    BLOOD, 2016, 128 (22)
  • [2] Reduced-Intensity Busulfan or TBI/Cyclophosphamide/Fludarabine-Based Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acquired Severe Aplastic Anemia
    Sun, R. -J.
    Wu, T.
    Xiong, M.
    Wei, Z. -J.
    Zhao, Y. -L.
    Cao, X. -Y.
    Liu, D. -Y.
    Lu, Y.
    Zhang, J. -P.
    Ji, S. -Q.
    Lu, D. -P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S439 - S439
  • [3] Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders
    Fraser, Ally
    Castillo, Paul
    Cascio, Erika
    Moore-Higgs, Giselle
    Farhadfar, Nosha
    Fort, John
    Slayton, William
    Lamba, Jatinder
    Horn, Biljana
    PEDIATRIC BLOOD & CANCER, 2023, 70 (07)
  • [4] Favorable Outcome with Durable Chimerism after Allogeneic Hematopoietic Cell Transplantation Using Busulfan and Fludarabine-Based Reduced-Intensity Conditioning for Children with Hemophagocytic Lymphohistiocytosis
    Koh, Kyung-Nam
    Kang, Sung Han
    Kim, Hyery
    Im, Ho Joon
    Suh, Jin Kyung
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S290 - S290
  • [5] FLUDARABINE-BASED SECOND TRANSPLANTATION FOR SECONDARY GRAFT FAILURE AFTER FIRST ALLOGENEIC STEM CELL TRANSPLANTATION
    Sun, Y.
    Xu, L.
    Liu, D.
    Liu, K.
    Huang, X.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S263 - S263
  • [6] Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease
    van Besien, K
    Bartholomew, A
    Stock, W
    Peace, D
    Devine, S
    Sher, D
    Sosman, J
    Chen, YH
    Koshy, M
    Hoffman, R
    BONE MARROW TRANSPLANTATION, 2000, 26 (04) : 445 - 449
  • [7] Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease
    K van Besien
    A Bartholomew
    W Stock
    D Peace
    S Devine
    D Sher
    J Sosman
    Y-H Chen
    M Koshy
    R Hoffman
    Bone Marrow Transplantation, 2000, 26 : 445 - 449
  • [8] Fludarabine-Based Conditioning Chemotherapy for Allogeneic Hematopoietic Stem Cell Transplantation in Acquired Severe Aplastic Anemia
    Al-Zahrani, Hazzaa
    Nassar, Amr
    Al-Mohareb, Fahad
    Al-Sharif, Fahad
    Mohamed, Said
    Al-Anazi, Khalid
    Patel, Moosa
    Rasheed, Walid
    Saleh, Abu Jafar Mohammed
    Bakr, Mahmoud
    Ahmed, Shad
    Ibrahim, Khalid
    Hussain, Fazal
    Elkum, Naser
    Elhassan, Tusneem
    Nurgat, Zubeir
    Chaudhri, Naeem
    Aljurf, Mahmoud
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 717 - 722
  • [9] Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
    Bornhäuser, M
    Storer, B
    Slattery, JT
    Appelbaum, FR
    Deeg, HJ
    Hansen, J
    Martin, PJ
    McDonald, GB
    Nichols, WG
    Radich, J
    Woolfrey, A
    Jenke, A
    Schleyer, E
    Thiede, C
    Ehninger, G
    Anasetti, C
    BLOOD, 2003, 102 (03) : 820 - 826
  • [10] Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major
    Roswitha Lüftinger
    Natalia Zubarovskaya
    Jacques-Emmanuel Galimard
    Annamaria Cseh
    Elisabeth Salzer
    Franco Locatelli
    Mattia Algeri
    Akif Yesilipek
    Josu de la Fuente
    Antonella Isgrò
    Amal Alseraihy
    Emanuele Angelucci
    Frans J. Smiers
    Giorgia La La Nasa
    Marco Zecca
    Tunc Fisgin
    Emel Unal
    Katharina Kleinschmidt
    Christina Peters
    Arjan Lankester
    Selim Corbacioglu
    Annals of Hematology, 2022, 101 : 655 - 665
12345